Biotech Breakthroughs and IP Challenges: The Future of Gene and Cell Therapy

Partners:

Lakshmikumaran & Sridharan

The webinar series bring together leading legal experts who will share the latest legal updates, decisions, and insights in live sessions over the week, ensuring you have the global perspective to stay ahead of the game.

Webinar Date: 14th November 2024 | Timings: 4:30 PM IST

Agenda:

CRISPR Patent Battle in Europe 

• Overview: Discussion on the Nobel Prize winners’ unexpected move to cancel their CRISPR patents, examining the legal, ethical, and strategic implications for IP ownership in gene editing technologies.
• Key Questions: What does this mean for the future of gene editing patents, and how will this decision impact global IP policies and innovation in biotech?

Gene and Cell Therapy IP Landscape 

• Topic Focus: Exploring the unique challenges and opportunities in patenting gene and cell therapies, including CRISPR-based innovations.
• Discussion Points: We will discuss best practices for securing patents, strategies for optimizing gene editing processes for precision and safety, and the importance of protecting advancements in cell and gene therapy manufacturing.

Patent Protection and Innovation in Manufacturing 

• Key Issues: Insight into safeguarding proprietary manufacturing processes for cell and gene therapies, a crucial aspect in biotech IP.
• Discussion: Effective IP strategies to support scale-up, safety, and quality in the production of gene and cell therapies, ensuring competitive advantage in a rapidly evolving industry.

Our Speaker:

Dr. Malathi Lakshmikumaran

Dr. Malathi Lakshmikumaran has more than 30 years of experience in the field of biochemistry and Molecular Biology with an expertise in plant genomics, DNA fingerprinting and genetic transformation.

Dr. Malathi serves as a Executive Director and heads the life science group at the IP division of the firm. She is a registered patent agent and has been actively engaged in preparing, filing and prosecuting of patent applications, both in India and abroad. She mainly works on pharmaceutical, chemical and biotechnological patent applications.

Dr. Malathi has successfully supervised several Ph.D. participants in the area of Molecular Biology and has more than 100 publications to her credit in various national & International journals.

Prior to joining the firm, she served as the Head, Centre for Bioresource & Biotechnology Division in The Energy and Resource Institute (TERI) for a period of 17 years.